108 related articles for article (PubMed ID: 1349324)
1. Termination of the B cell lymphoma dormant state in thymectomized AKR mice.
Haran-Ghera N; Peled A; Brightman BK; Fan H
J Immunol; 1992 May; 148(9):2947-52. PubMed ID: 1349324
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Ly-1+ B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice.
Rosner A; Peled A; Haran-Ghera N; Canaani E
Cancer Res; 1993 May; 53(9):2147-53. PubMed ID: 7683252
[TBL] [Abstract][Full Text] [Related]
3. Lymphomagenesis in AKR.Fv-1b congenic mice.
Haran-Ghera N; Peled A; Brightman BK; Fan H
Cancer Res; 1993 Jul; 53(14):3433-8. PubMed ID: 8324753
[TBL] [Abstract][Full Text] [Related]
4. Role of cytokines in termination of the B cell lymphoma dormant state in AKR mice.
Peled A; Tzehoval E; Haran-Ghera N
Leukemia; 1995 Jun; 9(6):1095-101. PubMed ID: 7596176
[TBL] [Abstract][Full Text] [Related]
5. The effects of passive anti-viral immunotherapy in AKR mice: II. Susceptibility to B cell lymphomagenesis.
Haran-Ghera N; Peled A; Canaani E; Caspi Y; Haimovich J; Shaft D; Resnitzky P; Brightman BK; Fan H
Leukemia; 1995 Nov; 9(11):1940-7. PubMed ID: 7475287
[TBL] [Abstract][Full Text] [Related]
6. Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3.
Hays EF; Bristol GC; McDougall S; Klotz JL; Kronenberg M
Cancer Res; 1989 Aug; 49(15):4225-30. PubMed ID: 2545338
[TBL] [Abstract][Full Text] [Related]
7. Observations on lymphomagenesis and lymphoma in AKR mice. A description of prelymphoma changes in the thymus and phenotypic diversity of lymphomas induced by SL3-3 virus.
Hays EF; Bristol G
Thymus; 1992 Jun; 19(4):219-34. PubMed ID: 1385666
[TBL] [Abstract][Full Text] [Related]
8. The effects of passive antiviral immunotherapy in AKR mice: I. The susceptibility of AKR mice to spontaneous and induced T cell lymphomagenesis.
Haran-Ghera N; Peled A; Wu L; Shortman K; Brightman BK; Fan H
Leukemia; 1995 Jul; 9(7):1199-206. PubMed ID: 7630195
[TBL] [Abstract][Full Text] [Related]
9. Enhanced AKR leukemogenesis by the dual tropic viruses. I. The time and site of origin of potential leukemic cells.
Haran-Ghera N; Peled A; Leef F; Hoffman AD; Levy JA
Leukemia; 1987 May; 1(5):442-9. PubMed ID: 2823020
[TBL] [Abstract][Full Text] [Related]
10. Prevention of T-cell lymphoma in AKR/J mice.
Peled A; Haran-Ghera N
Leukemia; 1988 Dec; 2(12 Suppl):125S-131S. PubMed ID: 2848990
[TBL] [Abstract][Full Text] [Related]
11. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
12. Prevention of spontaneous AKR T cell lymphomagenesis by 24-666, a virus isolated from an AKR B cell lymphoma.
Peled A; Haran-Ghera N
Virology; 1991 Apr; 181(2):528-35. PubMed ID: 1673038
[TBL] [Abstract][Full Text] [Related]
13. Progression to development of lymphoma in the thymus of AKR mice treated neonatally with SL 3-3 virus.
Hays EF; Bristol GC; Lugo JP; Wang XF
Exp Hematol; 1989 Dec; 17(11):1116-21. PubMed ID: 2511036
[TBL] [Abstract][Full Text] [Related]
14. Extrathymic maturation of alpha beta T cells from hemopoietic stem cells.
Dejbakhsh-Jones S; Jerabek L; Weissman IL; Strober S
J Immunol; 1995 Oct; 155(7):3338-44. PubMed ID: 7561027
[TBL] [Abstract][Full Text] [Related]
15. High incidence of B cell lymphomas derived from thymectomized AKR mice expressing TL.4 antigen.
Peled A; Haran-Ghera N
J Exp Med; 1985 Sep; 162(3):1081-6. PubMed ID: 3897447
[TBL] [Abstract][Full Text] [Related]
16. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
17. Development of murine lupus in CD4-depleted NZB/NZW mice. Sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity.
Connolly K; Roubinian JR; Wofsy D
J Immunol; 1992 Nov; 149(9):3083-8. PubMed ID: 1357036
[TBL] [Abstract][Full Text] [Related]
18. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
Brooks KH; Vitetta ES
J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
[TBL] [Abstract][Full Text] [Related]
19. Role of CD4+ and CD8+ cell subsets during amplification of natural T cell activity against IgG2ab in Igha mice and during induction of IgG2ab allotype suppression in Igha/b mice.
Majlessi L; Benaroch P; Denoyelle C; Bordenave G
J Immunol; 1993 Aug; 151(4):1859-67. PubMed ID: 8102153
[TBL] [Abstract][Full Text] [Related]
20. Proviral structure and differentiation antigen phenotype of spontaneous and chemically induced AKR lymphomas.
Richie ER; Nairn RS; Becker FF
Cancer Res; 1985 Jun; 45(6):2802-6. PubMed ID: 2985253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
